-
Breaking the cycle of obesity, inflammation, disease
New findings bode well for U-M clinical trials on a drug that could reverse obesity, Type 2 diabetes, and fatty liver disease.
New findings bode well for U-M clinical trials on a drug that could reverse obesity, Type 2 diabetes, and fatty liver disease.